U.S. Investors Swarm China's Biotech Leader

U.S. Investors Swarm China's Biotech Leader


Depositary shares of the up-and-coming Chinese biotech firm BeiGene jumped 15% today, to $118, after the company successfully raised $750 million in a follow-on share offering. BeiGene has promising drugs under development, ample funding, and international partners like Celgene and Boehringer Ingelheim .



from Biotech News